C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 221/10 (2006.01) A61K 31/40 (2006.01) A61K 31/435 (2006.01) A61P 1/00 (2006.01) A61P 9/00 (2006.01) A61P 25/00 (2006.01) C07D 209/62 (2006.01) C07D 491/04 (2006.01)
Patent
CA 2276098
The present invention is concerned with novel benzo[e]-isoindoles and benzo[h]isoquinolines of the general formula (see formula I) Since the compounds in accordance with the invention can bind to serotonin receptors (5HT2), they are especially suitable for the treatment or prevention of central nervous disorders such as depressions, bipolar disorders, anxiety states, sleep and sexual disorders, psychoses, schizophrenia, migraine and other conditions associated with cephalic pain or pain of a different kind, personality disorders or obsessive-compulsive disorders, social phobias or panic attacks, mental organic disorders, mental disorders in childhood, aggressivity, age-related memory disorders and behavioural disorders, addiction, obesity, bulimia, etc., nervous system damage caused by trauma, stroke, neurodegenerative diseases, etc.; cardiovascular disorders such as hypertension, thrombosis, stroke, etc; and gastrointestinal disorders such as dysfunction of the gastrointestinal tract motility.
L'invention concerne de nouveaux benzo[e]isoindoles et benzo[h]isoquinoléines tricycliques. Etant donné que ces composés peuvent se fixer aux récepteurs de sérotonine (5HT2), ils sont particulièrement appropriés pour le traitement ou la prévention de maladies du système nerveux central, telles que les dépressions, les troubles bipolaires, les états d'anxiété, les troubles du sommeil, les troubles sexuels, les psychoses, la schizophrénie, la migraine et d'autres états associés aux douleurs céphalées ou aux douleurs d'autre type, les troubles de la personnalité, les névroses obsessionnelles, les phobies sociales, les crises de panique, les maladies mentales organiques, les maladies mentales de l'enfance, l'agressivité, la perte de mémoire sénile, les troubles du comportement, la toxicomanie, l'obésité, la boulimie, les lésions du système nerveux provoquées par un traumatisme, une attaque; de maladies neurodégénératives, de maladies cardio-vasculaires, telles que l'hypertension, la thrombose, les attaques, ainsi que de maladies gastro-intestinales, telles que le dysfonctionnement de la motilité du tractus gastro-intestinal.
Boes Michael
Stadler Heinz
Wichmann Juergen
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Tricyclic benzo[e]isoindoles and benzo[h]isoquinolines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic benzo[e]isoindoles and benzo[h]isoquinolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic benzo[e]isoindoles and benzo[h]isoquinolines will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1374649